US 9,724,313 · Application 13/315,397 · Granted Aug 8, 2017
US 9,724,313
Pharmaceutical composition for use in medical and veterinary ophthalmology
Estimated expiration
November 17, 2029
3y 49d remaining
- Could not fetch continuity data for application PCTRU2009000295: Resource not found (404)
Earliest effective filing
Jun 10, 2009
+ 20 years
Jun 10, 2029
PTA +160d
Nov 17, 2029
No TD
—
Final
Nov 17, 2029
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- December 9, 2011
- Earliest effective filing
- June 10, 2009
- Issue date
- August 8, 2017
- PTA
- +160 days
- Base expiry (before PTA)
- June 10, 2029
June 10, 2009 + 20 years = June 10, 2029 + 160 PTA days = November 17, 2029
- Continuation-in-part of application PCTRU2009000295, filed Jun 10, 2009
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 13/315,397 · US 9,724,313
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 9,724,313: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US9724313Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.